Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BRD7 Protein (AA 129-236) (His tag,DYKDDDDK Tag)

Recombinant BRD7-Protein exprimiert in Escherichia coli (E. coli).
Produktnummer ABIN2669646

Kurzübersicht für BRD7 Protein (AA 129-236) (His tag,DYKDDDDK Tag) (ABIN2669646)

Target

Alle BRD7 Proteine anzeigen
BRD7 (Bromodomain Containing 7 (BRD7))

Protein-Typ

Recombinant

Spezies

  • 5
  • 2
Human

Quelle

  • 3
  • 2
  • 1
  • 1
Escherichia coli (E. coli)
  • Proteineigenschaft

    AA 129-236

    Aufreinigungstag / Konjugat

    Dieses BRD7 Protein ist gelabelt mit His tag,DYKDDDDK Tag.

    Produktmerkmale

    The peptide corresponding to amino acids 129 - 236 that contains the bromodomain sequences of BRD7 (accession number NM_013263.4) was expressed in E. coli and contains an N-terminal His tag and C-terminal FLAG tag with an observed molecular weight of 18.8 kDa. It shows binding specificity for acetylated H3K9, H3K14, H4K8, H4K12 and H4K16.
  • Möchten Sie weitere Optionen für dieses Protein ?

    !
    Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!
    Produkt
    Expressionssystem
    Konjugat
    Origin
    Preis ab
    Expressionssystem HEK-293 Cells
    Konjugat His tag
    Origin Human
    Preis ab 13.711,36 €
    Expressionssystem Cell-free protein synthesis (CFPS)
    Konjugat Strep Tag
    Origin Human
    Preis ab 20.480,57 €

    Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen

  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Handhabung

    Avoid repeated freeze/thaw cycles and keep on ice when not in storage.

    Lagerung

    -80 °C

    Informationen zur Lagerung

    Recombinant proteins in solution are temperature sensitive and must be stored at -80°C to prevent degradation.
  • Target

    BRD7 (Bromodomain Containing 7 (BRD7))

    Andere Bezeichnung

    BRD7

    Hintergrund

    Bromodomain-containing protein 7 (BRD7) belongs to the BET subclass of proteins, which are characterized by two N-terminal bromodomains and one ET (Extra Terminal) domain. BRDs associate with chromatin through their bromodomains that recognize acetylated histone lysine residues. Bromodomains function as 'readers' of these epigenetic histone marks and regulate chromatin structure and gene expression by linking associated proteins to the acetylated nucleosomal targets. The ET domain functions as a protein binding motif and exerts atypical serine-kinase activity. The BET family consists of at least four members in mouse and human, BRD2 (also referred to as FSRG1, RING3), BRD3 (FSRG2, ORFX), BRD4 (FSRG4, MCAP/HUNK1), and BRDT (FSRG3, BRD6). BRD7 interacts with several proteins, including DVL1, PTPN13, IRF2 and HNRPUL1 and functions in the regulation of transcriptional activation and chromatin remodeling. Specifically, BRD7 has been shown to bind dishevelled-1 (DVL1) and enhance Wnt signaling via inhibition of GSK3β. BRD7 also associates with histones and E1B-AP5. In particular, it binds acetylated histone peptides, most notably H3 peptide acetylated at Lys14. BRD7 also inhibits G1-S progression by transcriptional regulation of molecules in the Ras and Rb pathways. BRD7 also suppresses tumorigenicity through binding and acetylation of p53 that results in efficient recruitment of p53 to target promoters and subsequent oncogene-induced senescence.

    Molekulargewicht

    18.8 kDa
Sie sind hier:
Chat with us!